Author

A. R. Akram

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1

Frequent Co-Authors

D. A. Dorward· 3 shared L. Koppensteiner· 2 shared L. Mathieson· 2 shared R. O'Connor· 2 shared S. Pattle· 2 shared A. Byron· 1 shared A. von Kriegsheim· 1 shared H. F. Titmarsh· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. A. Dorward

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

H. F. Titmarsh, A. von Kriegsheim, J. C. Wills, R. A. O'Connor, K. Dhaliwal, M. C. Frame, S. B. Pattle, D. A. Dorward, A. Byron, A. R. Akram

The paper identifies tumour-specific ECM proteome signatures in NSCLC patients using mass spectrometry, finding 161 differentially regulated matrisome proteins and two novel extracellular markers associated with poorer survival.

bioRxiv · Sep 29, 2022 · PreprintCancer Biology

Location of CD39+ T cell sub-populations within tumours predict differential outcomes in non-small cell lung cancer.

L. Koppensteiner, L. Mathieson, S. Pattle, D. A. Dorward, R. O'Connor, A. R. Akram

The paper identifies CD39+ T cell sub-populations in NSCLC tumors and shows their spatial distribution correlates with patient outcomes.

bioRxiv · Sep 29, 2022 · PreprintCancer Biology

Subpopulations of cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer are a predictor of poor clinical outcome

L. Mathieson, L. Koppensteiner, S. Pattle, D. A. Dorward, R. O'Connor, A. R. Akram

The paper identifies CAF subtypes in NSCLC using flow cytometry and scRNA-seq, showing CAF-S1 and CAF-S5 are associated with poor patient survival.

bioRxiv · Sep 28, 2022 · PreprintCancer Biology